A clinical trial update dated November 13, 2026 reports on carbetocin, titled "Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium." The trial, registered as NCT06930391, is listed with status RECRUITING. The phase for this study is listed as not applicable. The study is examining carbetocin in relation to human myometrium contractility and extracellular calcium, according to the registry entry. No outcome data or results have been reported as part of this update. The listing does not state enrollment numbers, study duration, or any interim findings. Carbetocin remains classified as unapproved for research use in this context. This update reflects only the current recruitment status as recorded on ClinicalTrials.gov. No safety or efficacy conclusions can be drawn from a recruiting status alone. Readers interested in the broader context of carbetocin, including its regulatory status and other available information, can consult the compound overview for additional background.
Trial Update: Carbetocin Myometrium Study Recruiting as of Nov 2026
See the full carbetocin overview
Source: https://clinicaltrials.gov/study/NCT06930391